Package Leaflet: Information for the User
Cosentyx 75mg solution for injection in pre-filled syringe
secukinumab
Read all of this leaflet carefully before you (or your child) start using this medicine because it contains important information.
Contents of the pack
Cosentyx contains the active substance secukinumab. Secukinumab is a monoclonal antibody that belongs to a group of medicines known as "interleukin inhibitors". It works by neutralizing the activity of a protein called IL-17A, which is present in high amounts in diseases such as psoriasis, psoriatic arthritis, and axial spondyloarthritis.
Cosentyx is used to treat the following inflammatory diseases:
Pediatric plaque psoriasis
Cosentyx is used to treat a skin condition called "plaque psoriasis" that causes inflammation of the skin. Cosentyx reduces inflammation and other symptoms of the disease. Cosentyx is used in adolescents and children (from 6 years of age) with moderate to severe plaque psoriasis.
Using Cosentyx for plaque psoriasis will benefit you (or your child) as it improves the appearance of the skin and reduces symptoms such as scaling, itching, and pain.
Juvenile idiopathic arthritis, including enthesitis-related arthritis and juvenile psoriatic arthritis
Cosentyx is used in patients (from 6 years of age) to treat juvenile idiopathic arthritis in the categories called "enthesitis-related arthritis" and "juvenile psoriatic arthritis". These are inflammatory diseases that affect the joints and the places where tendons join the bone.
Using Cosentyx in enthesitis-related arthritis and juvenile psoriatic arthritis will benefit you (or your child) by reducing symptoms and improving physical function (or your child's).
Do not use Cosentyx:
If you suspect that you (or your child) are allergic, consult your doctor before using Cosentyx.
Warnings and precautions
Talk to your doctor, nurse, or pharmacist before using Cosentyx:
Tuberculosis
Tell your doctor if you (or your child) have or have had tuberculosis in the past and if you (or your child) know that you have recently been in close contact with someone who has tuberculosis. Your doctor will examine you (or your child) and may do a tuberculosis test before you (or your child) start Cosentyx. If your doctor thinks that you (or your child) are at risk of getting tuberculosis, you (or your child) may be given medicine to treat it. If you (or your child) get symptoms of tuberculosis (such as a persistent cough, weight loss, lack of energy, or a low-grade fever) while taking Cosentyx, tell your doctor right away.
Hepatitis B
Tell your doctor if you (or your child) have or have had a hepatitis B infection. This medicine may cause the infection to come back. Before and during treatment with secukinumab, your doctor may check you (or your child) for signs of infection. Tell your doctor if you notice any of the following symptoms: worsening tiredness, yellowing of the skin or the white part of the eyes, dark urine, loss of appetite, nausea, and/or pain in the upper right part of the stomach.
Inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Stop using Cosentyx and tell your doctor or seek medical help right away if you (or your child) notice stomach cramps and pain, diarrhea, weight loss, blood in the stool, or any other sign of bowel problems.
Watch for signs of infection and allergic reactions
Cosentyx may cause serious side effects, including infections and allergic reactions. You should watch for signs of these conditions while you (or your child) are using Cosentyx.
Stop using Cosentyx and tell your doctor or seek medical help right away if you (or your child) notice any of the signs of a possible serious infection or allergic reaction. These signs are listed in section 4 "Possible side effects".
Children and adolescents
Cosentyx is not recommended for use in children under 6 years of age with plaque psoriasis because it has not been studied in this age group.
Cosentyx is not recommended for use in children under 6 years of age with juvenile idiopathic arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis).
Cosentyx is not recommended for use in children and adolescents (under 18 years of age) for other indications because it has not been studied in this age group.
Other medicines and Cosentyx
Tell your doctor or pharmacist:
Pregnancy, breastfeeding, and fertility
Driving and using machines
Cosentyx is unlikely to affect your ability to drive or use machines.
Follow the instructions for administration of this medicine exactly as your doctor has told you. If you are not sure, ask your doctor, pharmacist, or nurse again.
Cosentyx is given by injection under the skin (i.e., subcutaneously). You and your doctor will decide if, after proper training, you should inject Cosentyx yourself or have a caregiver give the injection.
It is important that you do not try to inject Cosentyx until your doctor, nurse, or pharmacist has shown you how to do it.
Detailed instructions on how to administer Cosentyx can be found in the "Instructions for use of Cosentyx 75 mg pre-filled syringe" at the end of this leaflet.
Instructions for use can also be found via the following QR code and website:
'QR code to be included'
www.cosentyx.eu
How much Cosentyx to use and for how long
Your doctor will decide how much Cosentyx you (or your child) need and for how long.
Pediatric plaque psoriasis(children from 6 years of age)
Your doctor may increase the dose to 300 mg.
After the first dose, you (or your child) will receive injections every week for weeks 1, 2, 3, and 4, followed by monthly injections.
Juvenile idiopathic arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis)
After the first dose, you (or your child) will receive injections every week for weeks 1, 2, 3, and 4, followed by monthly injections.
Cosentyx is a long-term treatment. Your doctor will regularly check the condition of your (or your child's) disease to see if the treatment is working.
If you use more Cosentyx than you should
If you (or your child) receive more Cosentyx than you should or the dose has been given before the time indicated by your doctor, tell your doctor.
If you forget to use Cosentyx
If you have forgotten to inject a dose of Cosentyx, inject the next dose as soon as you (or your child) remember. Then talk to your doctor to find out when you should inject the next dose.
If you (or your child) stop using Cosentyx
It is not dangerous to stop using Cosentyx. However, if you do, it is possible that the symptoms of your (or your child's) psoriasis may come back.
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop using Cosentyx and tell your doctor or seek medical help right away if you (or your child) notice any of the following side effects:
Possible serious infection– the signs may include:
Severe allergic reaction– the signs may include:
Your doctor will decide if you (or your child) should and when to restart treatment.
Other side effects
Most of the following side effects are mild or moderate. If they become severe, tell your doctor, pharmacist, or nurse.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Frequency not known(cannot be estimated from the available data):
Reporting of side effects
If you (or your child) experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine:
Store the pre-filled syringe in its original carton to protect it from light. Store in a refrigerator at 2°C to 8°C. Do not freeze. Do not shake.
If necessary, Cosentyx can be left out of the refrigerator for a single period of up to 4 days at room temperature, not above 30°C.
This medicine is for single use only.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Cosentyx Composition
Appearance of Cosentyx and Container Contents
Cosentyx injectable solution is a clear liquid. Its color varies from colorless to slightly yellow.
Cosentyx 75 mg solution for injection in a pre-filled syringe is available in single-unit packs of 1 pre-filled syringe and in multi-packs containing 3 (3 packs of 1) pre-filled syringes.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Novartis Pharma GmbH
Roonstraße 25
90429 Nuremberg
Germany
Sandoz GmbH
Biochemiestrasse 10
6336 Langkampfen
Austria
Novartis Pharmaceutical Manufacturing GmbH
Biochemiestrasse 10
6336 Langkampfen
Austria
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
For further information, please contact the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien Novartis Pharma N.V. Tel: +32 2 246 16 11 | Lithuania SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
| Luxembourg/Luxemburg Novartis Pharma N.V. Tel: +32 2 246 16 11 |
Czech Republic Novartis s.r.o. Tel: +420 225 775 111 | Hungary Novartis Hungária Kft. Tel: +36 1 457 65 00 |
Denmark Novartis Healthcare A/S Tel: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Germany Novartis Pharma GmbH Tel: +49 911 273 0 | Netherlands Novartis Pharma B.V. Tel: +31 88 04 52 111 |
Estonia SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norway Novartis Norge AS Tel: +47 23 05 20 00 |
Greece Novartis (Hellas) A.E.B.E. Tel: +30 210 281 17 12 | Austria Novartis Pharma GmbH Tel: +43 1 86 6570 |
Spain Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Poland Novartis Poland Sp. z o.o. Tel: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tel: +33 1 55 47 66 00 | Portugal Novartis Farma – Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Croatia Novartis Hrvatska d.o.o. Tel: +385 1 6274 220 | Romania Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenia Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italy Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Finland Novartis Finland Oy Tel: +358 (0)10 6133 200 |
Cyprus Novartis Pharma Services Inc. Tel: +357 22 690 690 | Sweden Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvia SIA Novartis Baltics Tel: +371 67 887 070 |
Date of Last Revision of this Leaflet:11/2024
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu
Instructions for Use of Cosentyx 75 mg Pre-filled Syringe
Read ALL the instructions before injecting the medicine. It is important that you do not attempt to inject the medicine or a person under your care until a doctor, nurse, or pharmacist has taught you how to do it. The box contains a pre-filled syringe of Cosentyx 75 mg inside a plastic blister.
Your Cosentyx 75 mg Pre-filled Syringe

Once the medicine has been injected, the needle shield will be activated. This is designed to protect against accidental needlestick injuries to healthcare professionals, patients who self-inject the prescribed medicine, and individuals who assist patients with self-injection.
What you need for injection:
|
|
Important Safety Information
Warning: Keep the syringe out of sight and reach of children.
Storage of Cosentyx 75 mg Pre-filled Syringe
Injection Sites
| The injection site is the place where you will inject the syringe.
|
| If the person injecting is the patient's caregiver, the upper arm can also be used. |
Preparing Cosentyx 75 mg Pre-filled Syringe for Use
How to Use the Cosentyx 75 mg Pre-filled Syringe
| Carefully remove the needle cap from the syringe by holding the protective body of the syringe. Discard it. You may see a drop at the tip of the needle. This is normal. |
| Gently pinch the skin at the injection site and insert the needle as shown. Insert the needle completely at an angle of approximately 45 degrees to ensure that all the medicine is administered. |
| Hold the syringe as shown. Slowlypress the plunger all the wayso that the plunger head clicks into the activation clips of the shield. Keep pressing the plunger while keeping the syringe in that position for 5 seconds. |
| Without releasing the plunger, carefully remove the needle from the injection site. |
| Release the plunger slowly and let the shield automatically cover the needle. There may be a little blood at the injection site. You can press for 10 seconds with a cotton ball or gauze on the injection site. Do not rub the injection site. You can put a band-aid if needed. |
Disposal Instructions
| Dispose of the used syringe in a sharps disposal container (a closed and puncture-resistant container). For safety and health reasons (yours and others), used needles and syringes should never be reused. |
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for COSENTYX 75 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE – subject to medical assessment and local rules.